Left atrial (LA) volume is an important marker of cardiac dysfunction and cardiovascular outcome in heart failure (HF), but LA function is rarely measured.
Introduction
Breathlessness is a common presenting symptom in patients with heart failure (HF). The diagnosis of HF is usually made from a combination of clinical features and objective evidence of abnormal cardiac function, including raised plasma concentrations of natriuretic peptides. When left ventricular ejection fraction (LVEF) is low, the diagnosis is usually straightforward; but many patients have normal left ventricular systolic function and are labelled as having 'heart failure with normal ejection fraction', especially if other abnormalities of cardiac structure or function are present, such as a dilated left atrium (LA).
Increased LA dimensions and volumes indicate a higher risk of adverse cardiovascular outcomes for patients with HF with either a reduced or normal LVEF. 1 -5 The availability of newer imaging methods, including three-dimensional and speckle tracking echocardiography, has moved attention to more sophisticated and detailed study of the LA and its function. 6 -8 Although transthoracic echocardiography remains the simplest routinely available method of assessing the LA, it may be less accurate than cardiac magnetic resonance imaging (CMRI) or computer tomography. 9, 10 We measured LA function using CMRI and studied its relationship with other clinical variables and its ability to predict outcomes including incident atrial fibrillation (AF), HF admissions, and mortality in a large cohort of patients referred with symptoms that were thought suspicious of HF.
Methods

Study population
Consecutive outpatients referred with suspected HF to a community HF clinic who had undergone CMRI as part of their investigation were followed up prospectively. Heart failure was defined by the presence of symptoms or signs of HF supported by objective evidence of cardiac dysfunction: either a LVEF ,50% on CMRI or raised plasma concentration of amino-terminal pro-B-type natriuretic peptide (NTproBNP) .400 pg/mL (or .125 pg/mL if patients were taking loop diuretics) consistent with contemporary ESC guidelines. 11, 12 A clinical history, blood tests (including haematology, biochemistry profile, and NTproBNP), and electrocardiograms (ECGs) were obtained on the same day. Patients in AF or atrial flutter or those who had no available measurement of NTproBNP were excluded from this analysis (Supplementary material online, Figure S1 ).
Ischaemic heart disease (IHD) was defined as a previous history of myocardial infarction or .70% narrowing in at least one major epicardial artery on angiography.
We derived a congestion score based on lung auscultation (normal, basal, mid zone, or diffuse crepitations), jugular venous pressure (not visible, raised 1 -4, .4 cm above the angle of Louis), peripheral oedema (none, ankles, below, or above knees), and liver (not palpable, palpable) with one point attributed for each degree of severity. Patients with a score of ≥3 of a possible score of 9 were termed 'congested'.
Our hospital is the only one in the region offering acute medical services. We have access to both primary and secondary care records. Outcome is censored at the point of last medical contact in primary or secondary care. The vital status of all patients who have had no medical contact in the previous 6 months, unusual for patients with HF, is ascertained from national records. Data regarding deaths and hospitalisations were collected from the hospital's electronic systems, supplemented by information from patients, discharge letters, and their family doctors.
The primary outcome of interest was a composite of hospitalization for HF and all-cause mortality. Hospitalizations were considered to be due to HF if it was included in the death or discharge diagnosis and the discharge letter supported HF as a key reason for admission. Secondary endpoints were total mortality and cardiovascular mortality. Deaths were classified as sudden and attributed to a cardiovascular cause if they occurred out of hospital and were unexpected. Expected deaths were classified as those attributed to severe HF, respiratory disease, or advanced cancer.
A further secondary endpoint of incident, electrocardiographically documented AF was also considered. We did not attempt to distinguish between persistent and permanent AF.
This study conformed to the principles outlined in the Declaration of Helsinki and was approved by relevant ethical bodies. All subjects gave their written informed consent for additional research tests and for the use of their data for research purposes.
Cardiac magnetic resonance imaging measurements
Cardiac magnetic resonance imaging were acquired using a 1.5 T scanner (either Sigma CV/I, GE Medical Systems or Achieva, Philips Medical Systems) equipped with a phased-array coil placed over the praecordium. Patients lay in the supine position, and after localizing scans, ECG-gated cine images of the heart were acquired during breath-hold (in expiration) using steady-state free precession pulse sequences in two standard long axes and multiple short-axis slices, with slice thickness of 8 mm and interslice distance of 2 mm from the base to the apex of the heart. Images were analysed offline using QMass MR software (MEDIS, Leiden, The Netherlands). Left atrial maximum, the frame just before mitral valve opening, and minimum, the frame just after mitral valve closure, volumes were measured in both two-and four-chamber views by two experienced operators (P.P. and E.L.). The LA endocardial border was manually traced. The anterior border was at the mitral annular plane and the posterior border at the ostia of the pulmonary veins, excluding the LA appendage. Left atrial volumes were calculated using the area-length method (volume ¼ 0.85 × area 2 /length) and LA emptying function (LAEF) was calculated using the formula: [(LA max 2 LA min)/LA max] × 100%. We also calculated LA total emptying volume (reservoir function) using (LA max 2 LA min) and LA conduit volume using (LV stroke volume -LA total emptying volume). 13 The multislice, short-axis cine datasets were analysed to calculate LV and right ventricular (RV) volumes and masses. Endo-and epicardial borders were traced manually by an experienced observer on enddiastolic and end-systolic frames in contiguous short-axis slices. Left ventricular end-diastolic (EDV) and end-systolic volumes were calculated using summation of area × (slice thickness + interslice gap) for each slice (Simpson's method), which were then used to calculate LVEF and LV mass. Papillary muscles were excluded from LV volume measurements and included in mass calculations. The inter-ventricular septum was considered as part of the LV. Right ventricular volumes, mass, and EF were calculated in a similar fashion. Reliability and reproducibility have already been tested. 14 Mitral and tricuspid regurgitation volume was visually graded as none or trivial (0), mild (1), or moderate or worse (2) .
Statistical methods
Categorical data are presented as percentages, normally distributed continuous data as mean + standard deviation (SD) and non-normally distributed variables as median and interquartile range (IQR Associations between variables and prognosis were assessed using Cox proportional hazards (PH) models. In order to prevent overfitting, variables included in prognostic models were restricted to age, sex, NYHA (I/II vs. III/IV), IHD, congestion score 2 or less vs. ≥3, creatinine, albumin, haemoglobin, and left ventricular EDV. To these were added log[NTproBNP] and LAEF together and then separately. Forward and backward procedures were used to determine which variables independently predicted primary and secondary outcomes. Treatment variables were not included in the model as these are confounded by indication (patients who are sicker may be more likely to receive some treatments and less likely to tolerate others) and vary over time. Right ventricular measurements were not included in the multivariable analysis because these were available for only 549 patients with HF. The PH assumption was checked by the scaled Schoenfeld residual plot 15 and a global test of any PH violations were evaluated based on the method proposed by Grambsch and Therneau. 16 The overall model fit were evaluated by likelihood-ratio test and using the Cox-Snell residuals. The models fitted the data well. The discrimination of the model was accessed by Harrell's C. Kaplan -Meier curves with the log-rank statistic were used to illustrate outcome. Analyses were performed using SPSS and Stata software, a two-sided P-value of ,0.05 was considered statistically significant.
Reproducibility of measurements of left atrial volumes and emptying function
Twenty-five LA measurements (volumes and LAEF in two-and fourchamber views) were randomly selected and measured separately by two experienced operators blind to each other's results (P.P. and E.L.). The reproducibility of LA measurements was tested using the Bland-Altman method. Reproducibility of LAEF was good (mean difference for two-vs. four-chamber (+SD) for Operator 1: 21.44 + 3.96%; for Operator 2: 24.43 + 7.4%; inter-observer variability: mean difference (+SD) for LAEF for two-chamber view: 0.43 + 4.06%, mean difference for four-chamber view: 20.65 + 9.25%). A strong linear relation was found between LAEF measured in the two-and four-chamber views, overall (r ¼ 0.89; P , 0.001), for controls (r ¼ 0.75, P , 0.001) and for patients with HF (r ¼ 0.90, P , 0.001). The four-chamber view was used in subsequent analyses.
Results
Patient characteristics
Of 982 patients enrolled, 664 were in sinus rhythm and were considered to have HF. For patients with HF, median (IQR) age was 69 (61-75) years, median LVEF was 37 (29-46)%, and median plasma NTproBNP was 864 (388 -1978) ng/L. Of patients with HF, most were men (79%), had IHD (71%), and 82% had an LVEF of ,50% ( Table 1) .
Left atrial function: measurements and correlates
Left atrial volumes were larger and LAEF lower in patients with confirmed HF compared with those in whom the criteria for HF were not met. Patients with HF also had a lower LA reservoir volume.
Amongst patients with HF, those in the lowest quartile (worst function) of LAEF ( Table 1) had worse kidney and liver function, lower body mass index (BMI), higher plasma concentrations of NTproBNP and were taking more loop diuretics. They also had lower LVEF, larger LV, LA and RV volumes, higher LV and RV mass, and more mitral and tricuspid regurgitation when compared with those in the highest quartile. Left atrial emptying volume decreased as LAEF declined. In patients with HF, log LAEF was inversely related to log[NTproBNP] and directly to LVEF ( Table 2 ; adjusted R 2 ¼ 0.37). LAEF was similar in men and women (Supplementary material online, Table S1 ). LAEF was only weakly related to the severity of symptoms or congestion but this dissociation may be because patients with lower LAEF were prescribed higher doses of diuretics. Table 3) .
In a multivariable model including both log[NTproBNP] and LAEF in a four-chamber view, only increasing age, decreasing LAEF, and albumin were independent predictors of an adverse outcome. When LAEF was excluded, log[NTproBNP] entered the model. Similar results were obtained when LAEF measured in the twochamber view was used (Supplementary material online, Table S2 ).
Adding either LAEF or log(NTproBNP) to the standard set of clinical variables improved model discrimination and fit but adding LAEF was superior to NTproBNP. Adding NTproBNP to LAEF did not improve the model further (Supplementary material online, Table S3 ).
LAEF was similar in patients with HF in the top quartile of LAEF and those who did not fulfil the criteria for HF, but patients with HF had a worse outcome (HR 1.65, 95%CI: 1.06-2.57, P ¼ 0.027). For patients with HF, those in the lowest quartile of LAEF had the worst outcome [HR: 1.97 (95%CI: 1.45 -2.65, P , 0.001; HR: 1.88 (95%CI: 1.39 -2.54), P , 0.001 adjusted for age] (Figure 1 ).
All-cause mortality
During a median follow-up of 1390 days (IQR: 763-2342) censored at the time of death, 7 patients (7%) without and 202 patients (30%) with HF died. For patients with HF, LAEF, and RVEF, but not LVEF, predicted deaths in univariable analysis (Supplementary material online, Table S4 ). Maximum LA volume was not associated with an adverse outcome, even when it was indexed for body surface area (BSA).
In a multivariable model including both log[NTproBNP] and LAEF, increasing age, decreasing LAEF [HR: 2.72 (95%CI: 1.69-4.38), P , 0.001 for lowest vs. highest quartile; HR 2.50 (95%CI: 1.55 -4.02), P , 0.001 adjusted for age; Supplementary material online, Figure S2 ] and more severe congestion were independent predictors of mortality. When LAEF was excluded, log[NTproBNP] entered the model ( Table 4) .
Cardiovascular mortality
There were 110 CV deaths in patients with HF (54% of all deaths); 77 (70%) occurred in those with LVEF ,40%. In univariable analysis, decreasing LAEF and LVEF, but not RVEF, were associated with reduced survival (Supplementary material online, Table S5 ). In a multivariable model including both NTproBNP and LAEF, only increasing age and decreasing LAEF [HR: 3.65 (95%CI: 1.90-7.01), P , 0.001 lowest compared with highest quartile; HR: 3.40 (95%CI: 1.77-6.54), P , 0.001 adjusted for age] were independent predictors of CV mortality. When LAEF was excluded, log[NTproBNP] entered the model (Table 4) . (Figure 2 ).
Discussion
In patients referred with suspected HF, lower LAEF measured by CMRI is associated with higher plasma concentrations of NTproBNP, despite higher doses of diuretics, and with worse LV and RV function. LAEF is also a powerful predictor of incident AF, hospitalization for HF and of mortality in patients with HF whether or not they have LVSD. In contrast, measures of either LV or RV structure or function by MRI were only weak predictors of outcome.
MRI measurements of LA volumes and function can be done in most patients using either two-or four-chamber views with low intra-and inter-observer variation. Our findings confirm echocardiographic studies showing that measures of LA function are strongly . . .. ... ... ... ... ... ... ... ... ... ... ... .. ... ... .. ... ... ... ... ... ... ... ... ... ... ... ... . . ... ... ... ... ... ... ... .. ... ... ... ... ... ...   . ............ ............ ............ ............ ........... ............ ............ ............ ........... ............ ............ ............ ........... ............ ....... In the first column, the univariable analysis is shown; the second column shows a multivariable model, which includes both log(NTproBNP) and LAEF. In the last column, two different multivariable models have been tested: one excluding log(NTproBNP) and one excluding LAEF. Measurements of right ventricular size and function were not included in the multivariable analysis because these were available for only 549 patients with HF. Variables entered in multivariable models: age, sex, NYHA III vs. I/II, IHD, DM, COPD, Congestion ≥3, creatinine, haemoglobin, albumin, log(NTproBNP), LVEDV, and LAEF.
related to outcome not only in patients with systolic HF but also in those with a normal LVEF. 17, 18 However, LAEF might be more strongly related to morbidity and mortality than LA dimension or volume. Measuring LAEF using CMRI might add prognostic information in patients at risk of developing HF, such as those with hypertension. Kaminski and colleagues studied 210 patients with chronic hypertension and a normal LVEF. 19 Amongst all variables studied, including age, LVEF, and LA volume, LAEF was most strongly related to major adverse cardiac events in the following 2 years. Furthermore, in a recently published study, Gupta and colleagues showed that lower LAEF was associated with an adverse outcome even in the general population 20 but that LA maximal volume corrected for BSA (LA max /BSA) was only weakly associated with mortality. Our analysis also suggests that LA max is not a powerful prognostic marker. Because BSA is itself associated with mortality both in this and much larger HF datasets, 21 we decided to include it in the multivariable model as an independent variable rather than to correct our MRI measurements for BSA. The mechanism(s) linking LA function with outcome are not fully understood. Exposure to high LV filling pressures will cause an increase in LA volume and it may be that a decreased LAEF is just a marker of a sicker LV, agnostic to and integrating the effects of a decline in both systolic and diastolic performance. Short-term increases in LA myocardial stretch, such as may occur during exercise, will invoke the Frank-Starling mechanism, increasing LA contractility. 22 However, with sustained increases in LV and LA pressure, eccentric hypertrophy and dilation occurs and LA contractile reserve becomes exhausted. In end-stage HF, the LA becomes mainly a passive conduit dictated by ventricular distensibility. 23 These alterations are often mirrored on the right side of the heart, where chronic exposure to higher pulmonary venous and subsequently pulmonary arterial pressures leads to RV hypertrophy, dysfunction and dilation and eventually to worsening peripheral congestion. 24 -26 Many studies show that markers of congestion are strongly related to outcome and LAEF may be a useful measure of this pathophysiology. LAEF also predicts incident AF, which may trigger decompensation and increase mortality. 27 Conceptually, the prognosis of HF is driven by sudden death that may be due to arrhythmias or acute coronary events, 28 by worsening congestion and by co-morbid conditions that may act alone or in concert. It is likely that atrial dilatation and dysfunction and increasing plasma concentrations of natriuretic peptides are different aspects of the same process of increasing congestion. Although we did not observe an association between clinical features of congestion and atrial dysfunction or natriuretic peptides, this most likely reflects a confounding effect of diuretics. If all patients were given just 40 mg/day of furosemide, we suspect that clinical congestion would become much more obvious and severe in patients with low LAEF or raised NTproBNP. Observational studies, such as this, can only speculate on the nature of associations, but we suspect that declining atrial function and rising plasma concentrations of natriuretic peptides may have a common origin, reflecting rising LV filling pressures. However, some factors may differentially influence natriuretic peptides. Renal dysfunction may cause diuretic resistance and add to congestion but will also reduce the clearance of natriuretic peptides, causing a disproportionate rise relative to changes in LA volumes or function. Left atrial function in chronic heart failure Limitation Although this is a substantial study of patients with suspected HF referred for CMRI and followed up for a long period of time, with a large number of events and several measures of outcome considered, it has several limitations.
The indications for referral for cardiac MRI were not recorded and a referral bias for investigation by CMRI is likely; for instance, patients with implanted cardiac resynchronization or defibrillator devices will have been excluded. Younger patients may be more likely to be referred for and agree to MRI compared with frail elderly patients with advanced comorbidities. However, .25% of patients enrolled in this study were older than 75 years.
Most of the patients in whom HF was refuted as a diagnosis complained of exertional breathlessness. It is possible that some of their symptoms reflected reversible myocardial ischaemia or that some of them were simply unfit with high BMI. Their LAEF overlapped with those with HF in the highest quartile of LAEF but they had a higher LVEF, lower plasma concentrations of NTproBNP, and a better prognosis, suggesting that rejecting the diagnosis of HF was correct. The diagnosis of HF based on a raised NTproBNP but normal LVEF might also be questioned. The prognosis of these patients was substantially worse than patients in whom the diagnosis of HF was refuted [HR for the combined endpoint of hospitalization for HF and total mortality: 2.38 (95%CI: 1.53-3.71; P , 0.001); graph not shown], again suggesting that the diagnosis was correct.
In the clinical setting, it is probably simpler to measure LAEF by echocardiography, and newer tools are being developed to study LA deformation. Results from other large prospective studies are warranted not only to support or refute our findings. 30 We measured LAEF only in patients with sinus rhythm. One in five patients referred had AF. It is technically possible to measure the 'passive' LAEF caused by LA distension during mitral valve closure but we felt that there were too few patients with AF to provide a robust analysis that might only serve to complicate and confuse the results from patients in sinus rhythm.
Conclusion
Lower LAEF is associated with increasing plasma concentrations of NTproBNP, a higher incidence of AF and a poorer prognosis in patients with HF with or without LVSD. In multivariable models, LAEF and NTproBNP provide similar prognostic information. LAEF might be a useful way to monitor the progression of HF, regardless of the patient's LVEF, and could be a therapeutic target. However, this study should be viewed as of mechanistic rather than clinical importance, as NTproBNP provides similar prognostic information at lower cost and complexity.
